FDA Expands Evoke Neuroscience System Use Indications

Evoke Neuroscience achieved 510(k) marketing clearance to expand the indications for use on its eVox System.

The new indications are electroencephalography and event-related potentials to aid in clinical diagnoses.

The  device enables physicians to assess patients’ memory loss using the biomarkers it acquires.